RNLS
protein-codingrenalase, FAD dependent amine oxidase
Gene summary
Enables several functions, including NADH binding activity; epinephrine binding activity; and monoamine oxidase activity. Involved in negative regulation of blood pressure and negative regulation of heart rate. Located in extracellular region. Implicated in essential hypertension; hypertension; and stroke. Biomarker of end stage renal disease. [provided by Alliance of Genome Resources, Jun 2026]
- C10orf59
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~310.7 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0005129
Submitter: G2P
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to RNLS variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001031709.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 4 | 1 | 5 | |||
| missense | 56 | 6 | 2 | 64 | ||
| nonsense | 1 | 1 | ||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 1 | 1 | ||||
| Total | 0 | 0 | 57 | 11 | 3 | 71 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001026879.2 | 7 | MANE Select | |
| Ensembl | ENSP00000332530.4 | 7 | MANE Select | |
| RefSeq | NP_060833.1 | 7 | Standard | |
| Ensembl | ENSP00000361015.3 | 7 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Metabolism
- Nicotinamide salvaging
- Nicotinate metabolism
- Metabolism of water-soluble vitamins and cofactors
- Metabolism of vitamins and cofactors
Biological Process
- response to ischemia
- negative regulation of heart rate
- NAD biosynthesis via nicotinamide riboside salvage pathway
- negative regulation of blood pressure
- oxidation-reduction process
Molecular Function
- oxidoreductase activity, acting on NAD(P)H
- epinephrine binding
- NADH binding
- monoamine oxidase activity
Cellular Component
- extracellular region
- extracellular space
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000331772
- Coding exons
- 7
- Length
- 310667
- Individuals with no LoFs
- 125576
- Homozygous LoFs
- 1
- Heterozygous LoFs
- 171
- Defined
- 125748
- p
- 0.000684
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.0182 | 185 | 186 | 0.996 | 0.00000922 | 2218 |
| Missense (PolyPhen) | 64 | 61.667 | 1.0378 | 704 | ||
| Synonymous | 0.508 | 64 | 69.4 | 0.922 | 0.00000345 | 664 |
| Loss of Function | 1.38 | 11 | 17.2 | 0.640 | 7.93e-7 | 208 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00043 | 0.00043 | rare |
| Latino/Admixed American | 0.00075 | 0.00075 | rare |
| Ashkenazi Jewish | 0.00030 | 0.00030 | rare |
| East Asian | 0.00028 | 0.00027 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.00040 | 0.00040 | rare |
| South Asian | 0.0027 | 0.0027 | notable |
| Other | 0.00065 | 0.00065 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Catalyzes the oxidation of the less abundant 1,2- dihydro-beta-NAD(P) and 1,6-dihydro-beta-NAD(P) to form beta- NAD(P)(+). The enzyme hormone is secreted by the kidney, and circulates in blood and modulates cardiac function and systemic blood pressure. Lowers blood pressure in vivo by decreasing cardiac contractility and heart rate and preventing a compensatory increase in peripheral vascular tone, suggesting a causal link to the increased plasma catecholamine and heightened cardiovascular risk. High concentrations of catecholamines activate plasma renalase and promotes its secretion and synthesis. {ECO:0000269|PubMed:15841207, ECO:0000269|PubMed:17385068, ECO:0000269|PubMed:25531177}.;
Recessive Scores
- pRec
- 0.115
Intolerance Scores
- LoFtool
- 0.234
- RVIS EVS
- 0.84
- RVIS percentile EVS
- 88.3
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.0204
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | High |
| Cancer | Medium | Medium | Medium |